The Change of Alveolar-capillary Barrier by Germanium in Acute Lung Injury Induced by Lipopolysaccharide

LPS에 의한 급성 폐손상에서 게르마늄에 의한 폐포-모세혈관 장벽의 변화

  • 이윤정 (영남대학교 이과대학 생물학과) ;
  • 조현국 (경운대학교 안경광학과) ;
  • 신건호 (영남대학교 이과대학 생물학과) ;
  • 전경희 (영남대학교 이과대학 생물학과)
  • Published : 2009.03.31

Abstract

Acute respiratory distress syndrome (ARDS), also known as an acute inflammatory lung disease is developed by various factors that is originated from the destruction of alveolar-capillary barrier, and neutrophils plays an important role in the destruction. The study intended to confirm, the anti-inflammatory effect of germanium, whether a lung injury has been mitigated with the reduction of injury in alveolar-capillary barrier resulting from inhibition of neutrophils migration in lung tissue. Test groups were divided in saline administered CON, 5 hours of endotoxin administered LPS and 5 hours of endotoxin administered Ge+LPS following 1 hours of pre-processed germanium. $100{\mu}g$ endotoxin was melted in 0.5 mL saline and sprayed into airway and 26 mg germanium per 100 g weight was administered into abdominal cavity. The endotoxin group which induced an acute lung injury with administered endotoxin showed dramatic increase of pulmonary edema (p<0.001), protein contents in bronchoalveolar lavage fluid, BALF (p<0.05) and neutrophils of infiltration in BALF (p<0.001) comparing with a control group, while a pre-treated germanium group showed significant decrease in all categories comparing to the endotoxin administerd group. In the result of a microscopic observation, the structure of alveolar-capillary barrier which is constructed with basal lamina, alveolar type I cells and endothelial cell were preserved of the pre-treated germanium group relatively well compare to the endotoxin administered group. And the construction of lamellar body, microvilli and basal lamina of alveolar type II cells were also preserved relatively well. Hence, germanium activates as an anti-Inflammatory mediator in other words, it interfered neutrophils migration into lung tissue, thereby reduced injury of alveolar-capillary barrier from toxic substances of activated neutrophils. Consequently, the study has determined that the acute lung injury induced by endotoxin has been decreased by the pre-treated germanium.

급성호흡곤란증후군은 다양한 원인에 의해 발생하는 급성 염증성 폐질환으로써 폐포-모세혈관 장벽의 파괴로부터 기인하며 파괴 기전에 호중구가 중요한 역할을 담당한다. 이에 대한 게르마늄의 항염증 효과 즉, 호중구의 폐조직 내 유주 억제로 인한 폐포-모세혈관의 손상의 감소로 폐손상이 경감되는지를 확인하고자 하였다. 실험군은 생리식염수를 투여한 대조군(CON), 내독소 5시간 투여군(LPS), 그리고 게르마늄 1시간 전처리 후 내독소 5시간 투여군(Ge+LPS)으로 나누었으며, 내독소는 $100{\mu}g$을 0.5 mL 생리식염수에 녹여 기도내로 분무하고, 게르마늄은 체중 100 g당 26 mg을 복강으로 투여하였다. 내독소의 주입으로 급성 폐손상을 유도시킨 내독소 투여군에서는 대조군과 비교하여 폐부종(p<0.001), 기관지폐세척액 내 단백질 함량(p<0.05), 호중구의 침윤(p<0.001)이 현저히 증가하였으나 게르마늄을 전처리 한 군은 내독소 투여군과 비교하여 모든 항목에서 유의하게 감소하였다. 현미경을 통한 관찰 결과에서도 게르마늄 전처리군은 내독소 투여군에 비해 내피세포, 제I형 폐포세포, 기저판으로 구성된 폐포-혈관장벽의 구조가 비교적 잘 보존되었고, 제II형 폐포세포의 Lamellar body와 미세융모 그리고 기저판의 구조도 비교적 정상적으로 보존된 상태로 나타났다. 그러므로 게르마늄은 항염증물질로 작용, 즉 호중구의 폐조직 내로의 유주현상을 방해하여 활성화된 호중구의 독성물질로 인한 폐포-모세혈관의 손상을 감소시킬 수 있었으므로 결과적으로 내독소로 유도된 폐손상은 게르마늄의 전처리에 의해 억제되었다고 판단된다.

Keywords

References

  1. Abraham E: Neutrophils and acute lung injury. Crit Care Med 31(4 Suppl) : S195-199, 2003 https://doi.org/10.1097/01.CCM.0000057843.47705.E8
  2. Asai K: Miracle cure organic germanium. Japan Pub. Inc, pp. 17-25, 1976a
  3. Asai K: On the medical properties of germanium. ASAI germanium Research Institute, Tokyo, Japan, pp. 1-6, 1976b
  4. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 12; 2(7511) : 319-323, 1967
  5. Aso H, Suzuki F, Yamaguchi T, Hayashi Y, Ebina T, Ishida N:Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol Immunol 29(1) : 65-74, 1985
  6. Baughman RP, Gunther KL, Rashkin MC, Keeton DA, Pattishall EN: Changes in the inflammatory response of the lung during acute respiratory distress syndrome: prognostic indicators. Am J Respir Crit Care Med 154(1) : 76-81, 1996 https://doi.org/10.1164/ajrccm.154.1.8680703
  7. Cho HG: Germanium increases alveolar macrophage engulfment of apoptotic neutrophils in acute lung injury induced by endotoxin. Korean J Electron Microscopy 35(4) : 84-90, 2005
  8. Dimartino MJ, Lee JC, Badger AM, Muirhead KA, Mirabelli CK, Hanna N: Antiarthritic and immunoregulatory activity of spirogermanium. J Pharmacol Exp Ther 236(1) : 103-110, 1986
  9. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA: Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 152(6 Pt 1) : 1818-1824, 1995 https://doi.org/10.1164/ajrccm.152.6.8520742
  10. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM: Adult respiratory distress syndrome : risk with common predispositions. Ann Intern Med 98(5 Pt 1) : 593-597, 1983 https://doi.org/10.7326/0003-4819-98-5-593
  11. Goldblum SE, Wu KM, Jay M: Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 59(6) : 1978-1985, 1985
  12. Hiroshi S, Hiroyuki K, Norihiro K: Oral administration study of biscarboxyethylgermanium sesquioxide in Senescence Accelerated mouse. An abstract of study conference of senescence accelerated mouse (8th), pp. 43-44, 1991
  13. Hudson LD, Milberg JA, Anardi D, Maunder RJ: Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151(2 Pt 1) : 293-301, 1995 https://doi.org/10.1164/ajrccm.151.2.7842182
  14. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA: Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J Clin Invest 84(5) : 1609-1619, 1989 https://doi.org/10.1172/JCI114338
  15. Milberg JA, Davis DR, Steinberg KP, Hudson LD: Improved survival of patients with acute respiratory distress syndrome (ARDS) : 1983-1993. JAMA 25; 273(4) : 306-309, 1995 https://doi.org/10.1001/jama.273.4.306
  16. Montgomery AB, Stager MA, Carrico CJ, Hudson LD: Causes of mortality in patients with the adult respiratory distress syndrome. Am Rev Respir Dis 132(3) : 485-489, 1985
  17. Pepe PE, Potkin RT, Reus DH, Hudson LD, Carrico CJ: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144(1) : 124-130, 1982 https://doi.org/10.1016/0002-9610(82)90612-2
  18. Pittet JF, Mackersie RC, Martin TR, Matthay MA: Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 155(4) : 1187-205, 1997 https://doi.org/10.1164/ajrccm.155.4.9105054
  19. Sasaki K, Ishikawa M, Monma K, Takanayaki G: Effect of carboxyethylgermanium sesquioxide (Ge-132) on the acute inflammation and CCl4-induced hepatic damage in mice. Pharmacometrics 27(6) : 1119-1131, 1984
  20. Sibille Y, Reynolds HY: Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis 141(2) : 471-501, 1990 https://doi.org/10.1164/ajrccm/141.2.471
  21. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA: Interleukin-8 induces neutrophil transendothelial migration. Immunology 72(1) : 65-72, 1991
  22. Sloane PJ, Gee MH, Gottlieb JE, Albertine KH, Peters SP, Burns JR, Machiedo G, Fish JE: A multicenter registry of patients with acute respiratory distress syndrome : Physiology and outcome. Am Rev Respir Dis 146(2) : 419-26, 1992 https://doi.org/10.1164/ajrccm/146.2.419
  23. Sung YK: Studies on the antitumor activities of organic germanium compounds and arsenic compounds. Department of pharmacy graduate school, Kyungsung University, 1997
  24. Suzuki F, Brutkiewicz RR, Pollard RB: Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132). Anticancer Res 6(2) : 177-182, 1986
  25. Suzuki F, Brutkiewicz RR, Pollard RB: Macrophage involvement in the protective effect of carboxyethylgermanium sesquioxide (Ge-132) against murine ascites tumors. Int J Immunotherapr 11 : 239-245, 1986
  26. Tate RM, Repine JE: Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis 128(3) : 552-559, 1983
  27. Vadas P, Browning J, Edelson J, Pruzanski W: Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediat 8(1) : 1-30, 1993
  28. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 4; 342(18) : 1334-1349, 2000
  29. Yang MK: Study of possibility as antioxidant of Ge-132. J Korean Beauty Society 7(2) : 87-95, 2001
  30. Zilberberg MD, Epstein SK: Acute lung injury in the medical ICU : comorbid conditions, age, etiology, and hospital outcome. Am J Respir Crit Care Med 157(4 Pt 1) : 1159-1164, 1998 https://doi.org/10.1164/ajrccm.157.4.9704088